SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.74+0.1%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Wasikowski who wrote (105)3/19/1997 11:46:00 AM
From: PR2501   of 9523
 
John could you please give me an idea of how much of a premium over earnings Pfizer would expect if some company were crazy enough to try to buy them out. Personally, I think that Glaxo should have bought them out in 1994. That would have made Glaxo a true player in this industry... instead they purchased Wellcome <tsk><tsk>

Say does anyone have any opinions about the following prescription benefit management companies:
Caremark, ValueRx, WellPoint. Do Caremark, and ValueRx still market Pfizers products?? Does anyone think that these PBMs are likely takeover targets??

Thanks in advance,

PR2501
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext